Publications
Publications
Show Results For
- All HBS Web
(4,029)
- Faculty Publications (637)
- December 2012 (Revised July 2013)
- Case
The “Chongqing Model” and the Future of China
By: Meg Rithmire
Since opening to the global economy in 1979, but especially since entering the WTO in 2001, China's economy grew at rates around 10% annually by attracting FDI and promoting exports. After the financial crisis that began in 2008 and depressed demand in the United... View Details
- November 2012 (Revised November 2013)
- Case
Persephone's Pomegranate: Crédit Agricole and Emporiki
By: Dante Roscini, Daniela Beyersdorfer and Jerome Lenhardt
In 2006 the French bank Crédit Agricole bought the Greek Emporiki bank, for €2.8 billion, at the peak of a bull market for bank takeovers. Six years, a major financial crisis, and €5.2 billion of losses later, in a context of great uncertainty in the European banking... View Details
- November 2012
- Supplement
Amylin Pharmaceuticals (B)
By: Richard G. Hamermesh and Carin-Isabel Knoop
Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the company remained unprofitable as sales plateaued. The small pharmaceutical... View Details
- October 2012 (Revised July 2014)
- Background Note
The Role of the Government in the Early Development of American Venture Capital
By: Josh Lerner and Tom Nicholas
Whether the government or markets, or a mixture of both, can provide efficient and effective incentives for encouraging entrepreneurial activity and new venture financing is an age-old question. Public promotion efforts are controversial and in most cases they tend to... View Details
- October 2012 (Revised March 2022)
- Case
Kleiner-Perkins and Genentech: When Venture Capital Met Science
By: Felda Hardymon and Tom Nicholas
Genentech is a rare success story in the biotechnology industry. Hundreds of billions of dollars of venture capital have been invested without the expected transformational effects. Established in 1976, Genentech was to develop the new science of recombinant DNA into... View Details
- October 2012
- Case
Romney vs. Obama and U.S. Energy Policy
By: Rawi Abdelal and Kaitlyn Tuthill
In 2012, the energy sector in the United States was demanding major reform. Prices of oil and gas had continued to cripple the middle and lower class as the U.S. economy slowly recovered. At the same time, the U.S. lagged behind developed economies in production of... View Details
- September 2012 (Revised September 2014)
- Case
Doing Business in Malaysia
By: C. Fritz Foley, Michael Shih-Ta Chen and Keith Chi-Ho Wong
This case focuses on the current business environment in Malaysia as of 2012 by introducing the main economic, political and cultural aspects of the country for those interested in doing business there. The advantages and challenges of investing and doing business in... View Details
- September 2012
- Teaching Note
Vodafone Japan (A), (B) and (C) (TN)
By: Juan Alcacer
The series of three cases is used in Harvard Business School's (HBS) elective course "Competing Globally" as the second case in the first module (Why?: Strategies to create value globally) (See "Competing Globally: Course Note for Instructors", HBS 713-422). The module... View Details
- September 2012
- Case
SCMS: Battling HIV/AIDS in Africa
By: Ananth Raman, Noel Watson, Santiago Kraiselburd and Emmanuel Akili
In 2005, USAID and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), created the Supply Chain Management System (SCMS) to procure and distribute essential medicines and supplies; provide technical assistance to transform existing supply chains; and... View Details
Keywords: HIV; AIDS; Procurement Coordination; Developing Countries; Healthcare; Public Health; Ethiopia; Supply Systems For Healthcare Delivery In Developing Countries; Healthcare Logistics Industry; Health Disorders; Health Care and Treatment; Service Delivery; Supply Chain Management; Logistics; Developing Countries and Economies; Programs; Transition; Strategy; Pharmaceutical Industry; Health Industry; Ethiopia; Africa
- July 2012
- Case
Generation Investment Management
By: Sandra J. Sucher and Matthew Preble
Examines the investment process of Generation Investment Management, a "sustainable" investing firm established in 2004 by David Blood and U.S. Vice President Al Gore. Places students in the position of David Lowish, director of global industrials, who must decide... View Details
- July–August 2012
- Article
The Growth Opportunity That Lies Next Door
By: G. Jones
This article uses the case of Natura, the largest Brazilian beauty company and one of the world's top twenty beauty companies, to explore how the logic of globalization is changing for corporations from emerging countries as growth opportunities in those countries... View Details
- June 2012
- Class Lecture
Why You're Not Buying Venezuelan Chocolate: The Provenance Paradox
By: Rohit Deshpandé
A product's country of origin establishes its authenticity. This is the provenance paradox. Consumers associate certain geographies with the best products: French wine, Italian sports cars, Swiss watches. Competing products from other countries - especially developing... View Details
Keywords: Global Business; Branding; Strategic Planning; Strategic Positioning; Emergent Countries; Consumer Perception; Developing Markets; Brands and Branding; Geographic Location; Globalized Markets and Industries; Perception; Emerging Markets; Product Positioning; Global Strategy; Marketing Strategy; Food and Beverage Industry; Venezuela
- 2012
- Book
Banks as Multinationals
By: G. Jones
This is a revised edition of a comparative, international study which looks at the history of multinational banks. Researchers from the United States, Japan, Europe, and Australia survey the evolution of multinational banks over time and suggest a conceptual framework... View Details
- April 2012
- Case
Bella Healthcare India
By: Dorothy Leonard and Sunru Yong
Bella Healthcare India was originally established in Bangalore as a low-cost manufacturing facility for a U.S.-based cardiology equipment developer. Under country manager Joseph Cherian it evolved considerably, developing its own research and development capabilities.... View Details
Keywords: India; Productivity; Organizational Development; International Business; R＆D; Cross-cultural Relations; Medical Equipment ＆ Devices; Joint Ventures; Medical Specialties; Research and Development; Product Development; Organizational Change and Adaptation; Strategy; Decision Choices and Conditions; Health Care and Treatment; Product Launch; Failure; Cross-Cultural and Cross-Border Issues; Medical Devices and Supplies Industry; Bangalore
- April 2012
- Article
Retail Doesn't Cross Borders: Here's Why and What to Do about It
By: Marcel Corstjens and Rajiv Lal
Most companies assume that the easiest way to grow is by investing overseas and that the developing world offers the best opportunities for boosting revenues and profits today. However, success abroad varies widely, and research shows that it's often tough to... View Details
- February 2012 (Revised April 2017)
- Case
Schneider Electric: Becoming the Global Specialist in Energy Management
By: John D. Macomber and Rachna Tahilyani
Global electrical products company assesses growth and market demands in India. Company must decide between a products acquisition or developing a service business. Students need to be aware of different country conditions, demands on implementation of different... View Details
- February 2012
- Article
Management Practices across Firms and Countries
By: Nicholas Bloom, Christos Genakos, Raffaella Sadun and John Van Reenen
For the last decade we have been using double-blind survey techniques and randomized sampling to construct management data on over 10,000 organizations across 20 countries. On average, we find that in manufacturing American, Japanese, and German firms are the best... View Details
Keywords: Management Practices and Processes; Competency and Skills; Governing Rules, Regulations, and Reforms; Organizations; Developing Countries and Economies; Economic Sectors; Performance; Business and Shareholder Relations; Private Equity; Multinational Firms and Management; United States; Germany; Japan; China; India
- 2012
- Case
ChemChina
By: F. Warren McFarlan, Donghong Li, Lei Li and Hong Zhang
ChemChina is China's largest basic chemical manufacturing firm. It was included in Fortune Global 500 in 2011 and 2012, ranked No. 475 and 402. Its sales revenue in 2011 was 179 billion yuan, and profit was 600 million yuan. The year-end total assets were 254.2 billion... View Details
- 2012
- Teaching Note
ChemChina (TN)
By: F. Warren McFarlan, Donghong Li, Lei Li and Hong Zhang
ChemChina is China's largest basic chemical manufacturing firm. It was included in Fortune Global 500 in 2011 and 2012, ranked No. 475 and 402. Its sales revenue in 2011 was 179 billion yuan, and profit was 600 million yuan. The year-end total assets were 254.2 billion... View Details
- December 2011
- Article
EXEMPLARY CONTRIBUTION: Transforming Mental Models on Emerging Markets
By: Charles Dhanaraj and Tarun Khanna
Economic growth in the Western world increasingly depends on meaningful engagement with emerging markets such as Brazil, China, India, South Africa, and Turkey. Business schools are responding with increased attention to these markets in their research and curricula.... View Details